Aller au contenu principal
Profil bibliographique

Yao Ma

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

24Publications signalées
103Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

SARS-CoV-2 and COVID-19 ResearchInfluenza Virus Research StudiesCOVID-19 Clinical Research StudiesRNA and protein synthesis mechanismsAnimal Virus Infections Studies

Les publications récentes

Accès ouvert 2026 preprint OpenAlex

Development and characterization of mouse-adapted recombinant SARS-CoV-2 expressing reporter genes

Sara Hussein Mahmoud, Nathaniel D. Jackson, Ramya S. Barre, Yao Ma et autres

Abstract Transgenic K18-hACE2 mice are a standard model for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), albeit with limitations. A mouse-adapted 30 (MA30) SARS-CoV-2 has been developed to allow infection of wild-type (WT) mice strains. However, SARS-CoV-2 MA30 cannot be easily tracked …

us, Égypte (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2026 article OpenAlex

Potassium-Solubilizing Bacteria Mediate Light-Potassium Synergy to Enable Native Pueraria lobata to Outcompete Invasive Mikania micrantha

Yao Ma, Qiao Xu, Feng Sun, Xiaomin Wang et autres

The invasive vine Mikania micrantha H. B. K. poses severe threats to biodiversity and ecosystem stability in tropical and subtropical regions, calling for sustainable ecological approaches. This study explores how the native legume Pueraria lobata var. thomsonii Benth displaces M. micrantha in …

cn (code pays fourni par la source)

0 citations Microbial Ecology
Accès ouvert 2025 preprint OpenAlex

A cocktail of SARS-CoV-2 spike stem helix domain and receptor binding domain human monoclonal antibodies prevent the emerge of viral escape mutants

Yao Ma, Chengjin Ye, Michael S. Piepenbrink, Sara Hussein Mahmoud et autres

ABSTRACT Neutralizing antibodies (NAbs) targeting the spike (S) glycoprotein remain a crucial therapeutic strategy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, emerging viral variants have escaped all Food and Drug Administration (FDA)-approved NAb treatments, underscoring the urgent need for effective …

us, Égypte (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2025 preprint OpenAlex

Identification and characterization of a SARS-CoV-2 M pro G23 deletion ensitrelvir-resistant mutant

Yao Ma, Chengjin Ye, R Rahisuddin, Sarah Ahmed Mohamed Mahmoud et autres

ABSTRACT Ensitrelvir is an antiviral drug that specifically targets the main protease (M pro ) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been approved for the treatment of coronavirus disease 2019 (COVID-19) due to the conservation of its target protein …

us, Égypte (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2025 article OpenAlex

Structure and function of a cross-neutralizing influenza neuraminidase antibody that accommodates recent N2 NA Asn245 glycosylation

Xueyong Zhu, Ahmed Magdy Khalil, Michael S. Piepenbrink, Wenli Yu et autres

Monoclonal antibodies (mAbs) that recognize and inhibit a diverse range of influenza viruses, although relatively rare, have been isolated following infection or vaccination. Study of their ontology and mechanisms of action informs universal vaccine and therapeutic development. We have previously described a …

us (code pays fourni par la source)

0 citations Communications Biology
Accès ouvert 2025 preprint OpenAlex

Structure and function of a cross-neutralizing influenza neuraminidase antibody that accommodates recent N2 NA Asn245 glycosylation

Xueyong Zhu, Ahmed Magdy Khalil, Michael S. Piepenbrink, Wenli Yu et autres

Monoclonal antibodies (mAbs) that recognize and inhibit a diverse range of influenza viruses, although relatively rare, have been isolated following infection or vaccination. Study of their ontology and mechanisms of action informs universal vaccine and therapeutic development. We have previously described a …

us, Égypte (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2025 preprint OpenAlex

A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants

Yao Ma, Chengjin Ye, Ahmed Magdy Khalil, Sara Hussein Mahmoud et autres

The emergence of SARS-CoV-2 variants has necessitated continuous updating of vaccines. In contrast, antivirals remained effective as they target conserved viral proteins that are essential for the viral life cycle. However, several mutations in SARS-CoV-2 that may affect the efficacy of United …

us, Égypte (code pays fourni par la source)

3 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2025 article OpenAlex

Bioinformatics analysis and validation of novel biomarkers and competitive endogenous RNA networks involved in pyroptosis in diabetic nephropathy

Siyu Wu, Lan Yao, Wenxiang Zhang, Pengde Chen et autres

Diabetic nephropathy (DN) is one of the major complications of diabetes mellitus. Pyroptosis is a type of programmed cell death that is closely related to the development of DN, however the molecular mechanism of pyroptosis in the development of DN is still …

cn (code pays fourni par la source)

3 citations Scientific Reports
Accès ouvert 2025 article OpenAlex

Synergistic therapeutic effect of parecoxib and ilomastat combination in osteoarthritis via inhibition of IL-17/PI3K/AKT/NF-κB activity

Xiaofei Feng, Yao Ma, Yuhao Zhao, Zhenrui Zhao et autres

BACKGROUND: Osteoarthritis is a degenerative disease, and current drug treatment is to give nonsteroidal anti-inflammatory drugs to relieve symptoms. The anti-inflammatory ability of parecoxib and ilomastat has been confirmed, but the synergistic effect of combined administration in osteoarthritis has not been clear. …

cn (code pays fourni par la source)

6 citations Molecular Immunology
Accès ouvert 2024 article OpenAlex

Replication kinetics, pathogenicity and virus-induced cellular responses of cattle-origin influenza A(H5N1) isolates from Texas, United States

Ramya S. Barre, Anna Allué‐Guardia, Ruby A. Escobedo, Vinay Shivanna et autres

The host range of HPAIV H5N1 was recently expanded to include ruminants, particularly dairy cattle in the United States (US). Shortly after, human H5N1 infection was reported in a dairy worker in Texas following exposure to infected cattle. Herein, we rescued the …

us, mn, Égypte (code pays fourni par la source)

24 citations Emerging Microbes & Infections
Accès ouvert 2024 article OpenAlex

Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants

Michael S. Piepenbrink, Ahmed Magdy Khalil, Ana C. Chang, Ahmed Mostafa et autres

SARS-CoV-2 continues to be a public health burden, driven in-part by its continued antigenic diversification and resulting emergence of new variants. By increasing herd immunity, current vaccines have improved infection outcomes for many. However, prophylactic and treatment interventions that are not compromised …

us, Égypte, mn (code pays fourni par la source)

11 citations npj Viruses
2024 preprint OpenAlex

Replication Kinetics, Pathogenicity and Virus-induced Cellular Responses of Cattle-origin Influenza A(H5N1) Isolates from Texas, United States

Ahmed Mostafa, Ramya S. Barre, Anna Allué‐Guardia, Ruby A. Escobedo et autres

Abstract The host range of HPAIV H5N1 was recently expanded to include ruminants, particularly dairy cattle in the United States. Shortly after, human H5N1 infection was reported in a dairy worker in Texas following exposure to infected cattle. Herein, we rescued the …

us (code pays fourni par la source)

1 citation bioRxiv (Cold Spring Harbor Laboratory)

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.